Every new medicine, medical technology, or treatment we rely on today — ones that we take for granted when we walk into a pharmacy to fill a prescription or to purchase pain relievers — stems from one collective source: research. It is intrinsic to the advancement of healthcare. Without research there would be no new treatments or cures.
The good news is that more children survive cancer now than ever before, as doctors are able to cure nearly 80 percent of patients. But that doesn’t mean that those pediatric patients who survive cancer stop fighting once their treatment ends, because many face a variety of physical and emotional challenges as a result of their treatment.
Proton therapy, which uses high-energy subatomic particles, may offer a precise, organ-sparing treatment option for children with high-risk forms of neuroblastoma, the most common solid tumor of early childhood.
Investigators at Children’s Hospital work tirelessly to uncover the inner workings of biological systems and the causes of diseases.
A new study detailing the largest-ever genetic analysis of blood pressure in African Americans has identified five gene variants linked to the trait.
Sleep experts have conducted the first multicenter clinical trial of obstructive sleep apnea in children and have found that those who underwent surgery to remove their adenoids and tonsils had notable improvements in behavior, quality of life and other symptoms compared to those treated with “watchful waiting” and supportive care.
Orphan diseases represent a collection of disorders that afflict less than 200,000 individuals for any single disease type, yet there are more than 7,000 distinct orphan diseases.